Gilteritinib as a New Option for the Treatment of Relapsed/Refractory Acute Myeloid Leukemias with FLT3 Gene Mutation: A Literature Review and Three Case Reports

Acute myeloid leukemias (AML) are the most ubiquitous of all adult leukemias. The prognosis of the disease depends on its genetic profile. The mutation in FLT3 gene, which codes FMS-like tyrosine kinase 3, is observed in 1/3 of patients and is responsible for a high rate of relapses. The prognosis o...

Бүрэн тодорхойлолт

Номзүйн дэлгэрэнгүй

Үндсэн зохиолчид:	D. V. Motorin, L. L. Girshova, E. G. Lomaia, Yu. A. Alekseeva, A. V. Petukhov, V. V. Ivanov, E. K. Antonov, S. V. Efremova, A. I. Reshetova, E. N. Tochenaya, Aleksina Alekseevna Shatilova, A. V. Petrov, T. S. Nikulina, K. V. Bogdanov, D. V. Ryzhkova, Yu. V. Mirolyubova, I. E. Prokop’ev, I. G. Budaeva
Формат:	Artigo
Хэл сонгох:	Russo
Хэвлэсэн:	Practical Medicine Publishing House 2023-01-01
Цуврал:	Клиническая онкогематология
Нөхцлүүд:	acute myeloid leukemias flt3 gilteritinib
Онлайн хандалт:	https://bloodjournal.ru/index.php/coh/article/view/8
Шошгууд:	Шошго нэмэх Шошго байхгүй, Энэхүү баримтыг шошголох эхний хүн болох!